GlassScriptPrepare for your visit
Jeff M Sands
Nephrology (Internal Medicine) · Atlanta, GA · NPI 1174552509
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$4,654.61
in general payments reported to CMS, 2019-2025 · $72.80 in 2025
The $72.80 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Who reported paying
General payments only, top 3 by amount.
- E.R. Squibb & Sons, L.L.C. $4,200.00
- Astrazeneca Pharmaceuticals LP $381.81
- Travere Therapeutics, INC. $72.80
Questions you might ask
- I saw Jeff Sands listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1051475/jeff-m-sands